IHS FormWeb
Approved Formulary
Search by name
Search by class
Show Therapeutic Classes
Browse alphabetically
Select...
NUM
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
High Alert
Restricted Medications
Renal Adjustment Policy
Therapeutic Interchange Policy
Hazard.Drug Handling(USP 800)
Hazardous Waste
Chemotherapy
IV to PO Conversion Policy
Black Box Warnings
Look-Alike/Sound-Alike
REMS
Staff Telephone Numbers
Add Formweb to your mobile device
Android
iOS
Home
QuickStart
Admin
IHS FormWeb
Approved Formulary
Search by name
Additional search options
Search by class
Show Therapeutic Classes
Browse alphabetically
Select...
NUM
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
High Alert
Restricted Medications
Renal Adjustment Policy
Therapeutic Interchange Policy
Hazard.Drug Handling(USP 800)
Hazardous Waste
Chemotherapy
IV to PO Conversion Policy
Black Box Warnings
Look-Alike/Sound-Alike
REMS
Staff Telephone Numbers
Search results for:
imipenem-cilastatin-relebactam
imipenem-cilastatin-relebactam
Restricted Medications
Infectious Disease Services use only
Brand names:
Recarbrio
Form
Strength
POWDER FOR INJECTION, INTRAVENOUS
500 mg-500 mg-250 mg
Display
Carbapenems
Class:
08120708
Medication comments:
Restricted Antibiotics List
Per policy, these drugs are subject to renal dosing adjustments by pharmacy.
View all
Renal Dosing Program
Generic + Route
(Brand)
• Indications
Usual Adult Dose
Comments
Renal Dosage Adjustments
imipenem-cilastatin-relebactam
IV
(
Recarbrio
©
)
1.25 gm q6h
(30 min infusion)
Restricted to ID only!
CrCl ≥ 90: No adjustment necessary
CrCl 60 - 89: 1 g q6h
CrCl 30 - 59: 750 mg q6h
CrCl 15 - 29: 500 mg q6h
CrCl <15: In the absence of data, 500 mg q12h may be considered.
HD/PD: 500 mg q6 - 8h
Last updated:
Sep. 3, 2025
Renal Adjustment Policy
UpToDate
FDA DailyMed Package Insert
MedLinePlus (Patient Information)
MSDS Online
UpToDate Lexidrug
(Brand)
• Indications
Comments
(Recarbrio©)
(30 min infusion)
Restricted to ID only!
CrCl 60 - 89: 1 g q6h
CrCl 30 - 59: 750 mg q6h
CrCl 15 - 29: 500 mg q6h
CrCl <15: In the absence of data, 500 mg q12h may be considered.
HD/PD: 500 mg q6 - 8h